Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The aim of the current study is to assess the spectrum of genetic variation in the BRIP1 gene among Korean high-risk breast cancer patients who tested negative for the BRCA1/2 mutation. Materials and Methods Overall, 235 Korean patients with BRCA1/2mutation–negative high-risk breast cancer were screened for BRIP1mutations. The entire BRIP1 gene was analyzed using fluorescent-conformation sensitive gel electrophoresis. In silico analysis of BRIP1 variants was performed using PolyPhen-2 and SIFT. Results A total of 20 sequence alterations including 12 exonic and eight intronic variants were found. Among the 12 exonic variants, 10 were missense and two were silent mutations. No protein- truncating mutation was found among the tested patients. Among the 10 missense variants, four (p.L263F, p.L340F, p.L474P, and p.R848H) were predicted to be pathogenic by both PolyPhen-2 and SIFT, and these variants were found in five patients. Of the four missense variants, p.L263F, p.L474P, and p.R848H localize to regions between the helicase motifs, while p.L340F resides in an iron-sulfur domain of BRIP1. Conclusion No protein-truncating mutation in BRIP1 was found among the tested patients. The contribution of BRIP1 variants is thought to be minor in Korean non-BRCA1/2 high-risk breast cancer.
Abstract
Purpose The aim of the current study is to assess the spectrum of genetic variation in the BRIP1 gene among Korean high-risk breast cancer patients who tested negative for the BRCA1/2 mutation. Materials and Methods Overall, 235 Korean patients with BRCA1/2mutation–negative high-risk breast cancer were screened for BRIP1mutations. The entire BRIP1 gene was analyzed using fluorescent-conformation sensitive gel electrophoresis. In silico analysis of BRIP1 variants was performed using PolyPhen-2 and SIFT. Results A total of 20 sequence alterations including 12 exonic and eight intronic variants were found. Among the 12 exonic variants, 10 were missense and two were silent mutations. No protein- truncating mutation was found among the tested patients. Among the 10 missense variants, four (p.L263F, p.L340F, p.L474P, and p.R848H) were predicted to be pathogenic by both PolyPhen-2 and SIFT, and these variants were found in five patients. Of the four missense variants, p.L263F, p.L474P, and p.R848H localize to regions between the helicase motifs, while p.L340F resides in an iron-sulfur domain of BRIP1. Conclusion No protein-truncating mutation in BRIP1 was found among the tested patients. The contribution of BRIP1 variants is thought to be minor in Korean non-BRCA1/2 high-risk breast cancer.
참고문헌 (25)
- Daly MB, "Genetic", familial high-risk assessment : breast and ovarian, 2010, pp.8, 562~594
- Hollestelle A, "Discovering moderate-risk breast cancer susceptibility genes", Curr Opin Genet Dev, 20, pp.268~276 (2010)
- 김지선, "The Basic Facts of Korean Breast Cancer in 2011: Results of a Nationwide Survey and Breast Cancer Registry Database", Journal of Breast Cancer, 17(2), pp.99~106 (2014), 한국유방암학회
- Kim H, "Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3, 922 Korean patients with breast and ovarian cancer", Breast Cancer Res Treat, 134, pp.1315~1326 (2012)
- Choi DH, "The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2mutation", Breast Cancer Res Treat, 112, pp.569~573 (2008)
- Kim JH, "PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2mutations", Breast Cancer Res Treat, 122, pp.303~306 (2010)
- Cantor SB, "BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function", Cell, 105, pp.149~160 (2001)
- Han SA, "The Korean Hereditary Breast Cancer(KOHBRA)study : protocols and interim report", Clin Oncol(R Coll Radiol), 23, pp.434~441 (2011)
- Seong MW, "Low contribution of BRCA1", 2 genomic rearrangement to high-risk breast cancer in the Korean population, 2009, pp.8, 505~508
- Ahn SH, "BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations", Cancer Lett, 245, pp.90~95 (2007)
- den Dunnen JT, "Mutation nomenclature extensions and suggestions to describe complex mutations : a discussion", Hum Mutat, 15, pp.7~12 (2000)
- Ameziane N, "Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1", 2 negative familial breast cancer, 2009, pp.118, 651~653
- Cantor SB, "Assessing the link between BACH1 and BRCA1 in the FA pathway", Cell Cycle, 5, pp.164~167 (2006)
- Seal S, "Truncating mutations in the Fanconi anemia J gene BRIP1are low-penetrance breast cancer susceptibility alleles", Nat Genet, 38, pp.1239~1241 (2006)
- Wong MW, "BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer", Breast Cancer Res Treat, 127, pp.853~859 (2011)
- De Nicolo A, "A novel breast cancer-associated BRIP1(FANCJ", BACH1)germ-line mutation impairs protein stability and function, 2008, pp.14, 4672~4680
- Kuusisto KM, "Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1", 2-founder mutation-negative breast and, Breast Cancer Res, pp.2011, 13[DOI]
- Cao AY, "Mutation analysis of BRIP1", BACH1 in BRCA1, Breast Cancer Res Treat, pp.2009, 115[DOI]
- Catucci I, "Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families", Fam Cancer, 11, pp.483~491 (2012)
- Cantor SB, "Hereditary breast cancer and the BRCA1-associated FANCJ", BACH1, Future Oncol, pp.2011, 7[DOI]
- Rudolf J, "The DNA repair helicases XPD and FancJ have essential ironsulfur domains", Mol Cell, 23, pp.801~808 (2006)
- Levran O, "The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia", Nat Genet, 37, pp.931~933 (2005)
- Wu Y, "Fanconi anemia group J mutation abolishes its DNA repair function by uncoupling DNA translocation from helicase activity or disruption of protein-DNA complexes", Blood, 116, pp.3780~3791 (2010)
- Gupta R, "Inhibition of BACH1(FANCJ)helicase by backbone discontinuity is overcome by increased motor ATPase or length of loading strand", Nucleic Acids Res, 34, pp.6673~6683 (2006)
- Wu Y, "DNA helicase and helicase-nuclease enzymes with a conserved iron-sulfur cluster", Nucleic Acids Res, 40, pp.4247~4260 (2012)